DekaBank Deutsche Girozentrale’s IGM Biosciences IGMS Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio IGMS Stock Details IGMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-6,303	Closed	-$50K	–	1501
2023 Q3	$50K	Buy	+6,303	New	+$53.5K	﹤0.01%	1392
2023 Q2	–	Sell	-9,100	Closed	-$153K	–	1282
2023 Q1	$153K	Hold	9,100	–	–	﹤0.01%	1217
2022 Q4	$147K	Hold	9,100	–	–	﹤0.01%	1264
2022 Q3	$176K	Hold	9,100	–	–	﹤0.01%	1248
2022 Q2	$165K	Hold	9,100	–	–	﹤0.01%	1220
2022 Q1	$235K	Buy	9,100 +800	+10%	+$14.9K	﹤0.01%	1180
2021 Q4	$241K	Buy	8,300 +200	+2%	+$9.94K	﹤0.01%	1239
2021 Q3	$530K	Hold	8,100	–	–	﹤0.01%	1033
2021 Q2	$668K	Hold	8,100	–	–	﹤0.01%	1000
2021 Q1	$600K	Hold	8,100	–	–	﹤0.01%	995
2020 Q4	$707K	Buy	+8,100	New	+$569K	﹤0.01%	948

Other funds holding IGMS

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

DekaBank Deutsche Girozentrale's IGMS Position: Q4 2023 in Review

DekaBank Deutsche Girozentrale sold out of IGM Biosciences (IGMS) in Q4 2023, closing a stake of 6,303 shares — an estimated $50K sold.

DekaBank Deutsche Girozentrale first reported a position in IGMS in Q4 2020 and held it in 11 quarters. The position peaked at $707K in Q4 2020. 72 funds tracked by Wall St. Rank hold IGMS as of Q4 2023.

DekaBank Deutsche Girozentrale reported no remaining IGM Biosciences position as of Q4 2023 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 6,303 IGM Biosciences shares in Q4 2023, an estimated $50K.
DekaBank Deutsche Girozentrale first reported a position in IGM Biosciences in Q4 2020 and held it in 11 quarters.
DekaBank Deutsche Girozentrale's IGM Biosciences position peaked at $707K in Q4 2020.
72 funds tracked by Wall St. Rank held IGM Biosciences as of Q4 2023.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q4 2023, filed 24 Jan 2024.